FDA Approves Segluromet (ertugliflozin and metformin hydrochloride) for Type 2 Diabetes. Segluromet is indicated as an adjunct to diet and
Category: Glycemic control
Ademlog for treating diabetes
FDA Approves Admelog (insulin lispro) Short-Acting “follow-on” insulin product to treat diabetes, it is a short-acting insulin indicated to improve
